The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

9 articles for BR Taft


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design and Discovery of N-(2-Methyl-5'-morpholino-6'-((tetrahydro-2H-pyran-4-yl)oxy)-[3,3'-bipyridin]-5-yl)-3-(trifluoromethyl)benzamide (RAF709): A Potent, Selective, and Efficacious RAF Inhibitor Targeting RAS Mutant Cancers.EBI
Novartis Institutes For Biomedical Research
Discovery and Preclinical Pharmacology of INE963, a Potent and Fast-Acting Blood-Stage Antimalarial with a High Barrier to Resistance and Potential for Single-Dose Cures in Uncomplicated Malaria.EBI
Novartis Institutes For Biomedical Research
Design and Discovery of EBI
Novartis Institutes For Biomedical Research
Indoleamine-2,3-dioxygenase inhibitor, preparation method therefor and use thereofBDB
Hinova Pharmaceuticals
Quinoline analogs as phosphatidylinositol 3-kinase inhibitorsBDB
Nanjing Zhengxiang Pharmaceuticals
WDR5 inhibitors and modulatorsBDB
Vanderbilt University
Indole derivatives and their use in neurodegenerative diseasesBDB
Merck Patent
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of useBDB
Merck Sharp & Dohme
Aggrecanase inhibitorsBDB
Eli Lilly